,
OTTAWA, November 7, 2017 (LifeSiteNews) — The Canadian government is expanding access to the abortion pill, including allowing the drug for abortions of children in utero of up to nine weeks gestation, and allowing pharmacists to dispense it directly, rather than requiring doctors to do so.
Health Canada made its decision based on evidence submitted by the drug’s sponsor, Linepharma, according to an information update the department released Tuesday.
Linepharma is represented in Canada by Celopharma.
Health Canada says it also undertook a “thorough review of new and existing scientific literature on the safe use and effectiveness of Mifegymiso.”
It has authorized the following:
Mifegymiso can now be prescribed up to nine weeks (63 days) into a pregnancy, rather than the previous limit of seven weeks (49 days). Mifegymiso can now be dispensed directly to patients by a pharmacist or a prescribing health professional. Health professionals are no longer required to complete an education program before they can prescribe Mifegymiso. The requirement for written patient consent to use Mifegymiso is being removed. Health professionals will no longer be required to register with Celopharma in order to prescribe or dispense Mifegymiso.
Action Canada for Sexual Health
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors